(349 days)
No reference devices were used in this submission.
No
The summary describes standard ultrasound image processing and does not mention any AI or ML capabilities.
No.
The device is described as an "Ultrasound Imaging System" intended for "diagnostic ultrasound echo imaging, measurement, and analysis of the human body." Its purpose is to create images for diagnosis, not to treat or provide therapy.
Yes
The "Intended Use / Indications for Use" section explicitly states, "The SONON Ultrasound Imaging System (Model: SONON 300C) is intended for diagnostic ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications." Additionally, the "Device Description" section refers to it as a "hand-held diagnostic ultrasound system."
No
The device description explicitly states that the system consists of a battery-operated, hand-held SONON Ultrasound Imaging System transducer, in addition to the software and mobile device/PC. This transducer is a hardware component essential for the device's function of emitting and receiving ultrasound waves.
Based on the provided information, the SONON Ultrasound Imaging System (Model: SONON 300C) is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use clearly states "diagnostic ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications". This describes a device used for imaging within the body, not for examining specimens outside the body.
- Device Description: The description details a system that uses pulsed-echo technology to transmit and receive ultrasound waves to create images of internal structures. This is the fundamental principle of diagnostic ultrasound, which is an in vivo imaging modality.
- Lack of IVD Characteristics: There is no mention of the device being used to examine biological specimens (like blood, urine, tissue samples) or to perform tests on these specimens to provide diagnostic information.
In Vitro Diagnostic devices are specifically designed to examine specimens taken from the human body to provide information for diagnosis, monitoring, or screening. The SONON Ultrasound Imaging System operates by interacting directly with the patient's body to generate images.
N/A
Intended Use / Indications for Use
The SONON Ultrasound Imaging System (Model: SONON 300C) is intended for diagnostic ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including obstetrics (OB), gynecology (GY) and general (abdominal) imaging. The system operating modes is B (Brightness), CF (color flow), PW (pulsed wave), M (motion). The intended to be used in a hospital or medical clinic is used by appropriately trained healthcare professionals, including radiologists, sonographers, technologists, and clinicians, in a medical facility.
Product codes
IYN, IYO, ITX
Device Description
The SONON Ultrasound Imaging System, Model: SONON 300C, is a wireless ultrasound system that uses pulsed-echo technology (frequency: 3.5 MHz; module: convex) to transmit ultrasound images via wireless communication to a mobile device that utilizes the iOS or Android, or PC that uses Windows operating system.
The minimum requirements for the mobile devices that utilize the iOS, Android or Windows operating system for use with the SONON Ultrasound Imaging System, Model: SONON 300C are as follows:
Operating system: iOS, Requirement: iOS 11.0 or later, Compatible Devices: iPhone 6S and newer, iPad 5 and newer, iPad Air 2 and newer, iPad Mini 4 and newer, iPad Pro and newer
Operating system: Android, Requirement: Android 5.0 (Lollipop) or later, Compatible Devices: Samsung Galaxy S6 and newer, Samsung Galaxy Note 5 and newer, Samsung Galaxy Tab S3 and newer
Operating system: Windows (UWP), Requirement: Windows 10 (64-bit) or later, Compatible Devices: Microsoft Surface Pro 3 and newer
The SONON Ultrasound Imaging System is a portable, general-purpose, softwarecontrolled, hand-held diagnostic ultrasound system that consists of
- (i) a commercial off-the-shelf iOS or Android mobile device, or Windows PC
- the SONON Ultrasound Imaging System software that runs as an app on the (ii) mobile device,
- the battery-operated, hand-held SONON Ultrasound Imaging System (iii) transducer that communicates wirelessly with iOS or Android mobile devices, and
- the instructions for use manual, battery, charger, and power cords. (iv)
The SONON software can be downloaded to an iOS, Android mobile device or Windows PC and utilizes an icon touch-based user interface. The software enables ultrasound image capture and review, controls for time gain, dynamic range, display of mirror image, focal length, depth, brightness, contrast, linear/elliptical measurement, color flow, and image annotation, as well as storage and PACS transmission of images and videos.
The SONON Ultrasound Imaging System allows the user to image in real time and review cine or freeze-frame images on the screen in a B-Mode and Color Flow Doppler (CF Mode) Mode with 2-dimensional scan format. In addition, PW (pulsed wave) mode displays different wave velocities and directions in a spectrum. Moreover, in M mode (also known as "motion mode"), the changes over time on a line graph appears in a spectrum.
All images and data collected are stored in the mobile app. If the app is removed and reinstalled, all stored information is lost and cannot be recovered.
The SONON Ultrasound Imaging System utilizes pulsed-echo technology to determine the depth and location of tissue interfaces, and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. Ultrasound waves are emitted from the transducer, propagate through tissues, and return to the transducer as reflected echoes. The returned echoes are then converted into electrical impulses by transducer crystals and further processed in order to form the ultrasound image presented on the screen.
The device components are not supplied sterile and do not require sterilization prior to use.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Human body for general clinical applications including obstetrics (OB), gynecology (GY) and general (abdominal) imaging.
Indicated Patient Age Range
For use in all patients
Intended User / Care Setting
Appropriately trained healthcare professionals, including radiologists, sonographers, technologists, and clinicians, in a hospital or medical clinic.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design control activities were conducted for the changes which may affect the acoustic output, clinical measurement range and accuracies, and Wi-Fi Connectivity.
The acoustic output exposure levels were measured, calculated, and derated following IEC 62359:2010/AMD1:2017. The test methodology for the measurement of acoustic output levels is exact same as a cleared device. Test result show that the acoustic output of modified device complies with the requirement for acoustic output level as per FDA Guidance "Marketing Clearance of Diagnostic Ultrasound Systems and Transducers", issued on June 27, 2019.
To support substantial equivalence to the predicate devices, Healcerion conducted performance test related to clinical measurement range accuracies such as vertical/horizontal resolution, maximal viewing depth, vertical/horizontal distance accuracy, acoustic output frequency, etc. The device met the pre-defined acceptance criteria for the performance test, and its results show that the changes are acceptable in perspective of safety and effectiveness of the device.
For Wi-Fi connectivity that support both 2.4 GHz and 5 GHz, performance test was conducted to ensure that the change in Wi-Fi driver on the device performs equivalently to the predicate devices.
NO clinical test nor animal study was performed to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
No reference devices were used in this submission.
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. Food & Drug Administration" in blue.
Healcerion Co., Ltd. % Jong Hyun Kim Senior Consultant GMS Consulting Co., Ltd. 34. Sangamsan-ro. Mapo-gu Seoul. 03909 REPUBLIC OF KOREA
May 16, 2022
Re: K211665
Trade/Device Name: SONON Ultrasound Imaging System, Model: SONON300C Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: April 18, 2022 Received: April 19, 2022
Dear Jong Hyun Kim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801and Part 809); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For
Michael D. O'Hara, Ph.D. Deputy Director DHT 8C: Division of Radiological Imaging and Radiation Therapy Devices OHT 8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below.
510(k) Number (if known)
Device Name
SONON Ultrasound Imaging System (Model: SONON 300C)
Indications for Use (Describe)
The SONON Ultrasound Imaging System (Model: SONON 300C) is intended for diagnostic ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including obstetrics (OB), gynecology (GY) and general (abdominal) imaging. The system operating modes is B (Brightness), CF (color flow), PW (pulsed wave), M (motion). The intended to be used in a hospital or medical clinic is used by appropriately trained healthcare professionals, including radiologists, sonographers, technologists, and clinicians, in a medical facility.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (6/20)
3
510(k) Summary
This summary of safety and effectiveness information is submitted in accordance with 21 CFR § 807.92.
1. Submitter
- Manufacturer . : HEALCERION Co., Ltd. Address : 1403-ho, 12, Digital-ro 33-gil, Guro-gu, Seoul, 08377 ● Korea Telephone No. . : +82-70-8217-0820 E-mail Address : peter@healcerion.com ● Contact ● : LEE SOOYEOL / CTO Information Email : peter@healcerion.com
2. Device Name and Classification
| • | Device Common/Usual Name | : Diagnostic Ultrasound System and Transducer |
|---|---|---|
| • | Device Proprietary Name | : SONON Ultrasound Imaging System, Model: |
| SONON 300C | ||
| • | Regulation Name | : System, Imaging, Pulsed Doppler, Ultrasonic |
| System, Imaging, Pulsed Echo, Ultrasonic | ||
| Transducer, Ultrasonic, Diagnostic | ||
| • | Device Classification | : Class II |
| • | Product Code | : IYN, IYO, ITX |
| • | Regulation Number | : 21 C.F.R. § 892.1550, § 892.1560, and § 892.1570 |
| • | Classification Panel | : Radiology |
Predicate Device 3.
The predicate devices of the subject device are as follows:
Predicate Device #1 (Primary Predicate Device)
4
| • | K Number | : K151339 |
|---|---|---|
| • | Manufacturer | : HEALCERION CO., LTD. |
| • | Device Common/Usual | |
| Name | : Diagnostic Ultrasound System and Transducer | |
| • | Device Proprietary Name | : SONON Ultrasound Imaging System, Model: |
| SONON 300C | ||
| • | Regulation Name | : System, Imaging, Pulsed Echo, Ultrasonic |
| • | Device Classification | : Class II |
| • | Product Code | : IYO, ITX |
| • | Regulation Number | : 21 C.F.R. § 892.1560, and § 892.1570 |
| • | Classification Panel | : Radiology |
Predicate Device #2 (Secondary Predicate Device)
| • K Number | : K192107 |
|---|---|
| • Manufacturer | : Clarius Mobile Health Corp. |
| • Device Common/Usual | |
| Name | : Diagnostic Ultrasound System and Accessories |
| • Device Proprietary Name | : Clarius Scanner C3 HD |
| • Regulation Name | : System, Imaging, Pulsed Echo, Ultrasonic |
| • Device Classification | : Class II |
| • Product Code | : IYN, IYO, ITX |
| • Regulation Number | : 21 C.F.R. § 892.1550, § 892.1560, and § 892.1570 |
| • Classification Panel | : Radiology |
Healcerion is not aware of any design-related recalls regarding the predicate devices. No reference devices were used in this submission.
Reason for Submission 4.
Following changes have been made compared to the cleared device (Predicate Device #1)
- Software (Mobile application) Changes: Windows 10 support, several features • added (Supporting Server Login, Quick Scan, etc.)
- Cybersecurity Measures implemented •
5
- Label Changes: Device label, Box label, User Manual
- Battery Cell and its nominal voltage changed
- Power Board changed to support additional modes (CF, PW, M Mode)
- . Wi-Fi driver changed to support both 2.4 GHz & 5GHz connectivity
- A measuring mode added which is designed for assessing fetal biometry
- Available display depth range changed ●
5. Device Description
The SONON Ultrasound Imaging System, Model: SONON 300C, is a wireless ultrasound system that uses pulsed-echo technology (frequency: 3.5 MHz; module: convex) to transmit ultrasound images via wireless communication to a mobile device that utilizes the iOS or Android, or PC that uses Windows operating system.
The minimum requirements for the mobile devices that utilize the iOS, Android or Windows operating system for use with the SONON Ultrasound Imaging System, Model: SONON 300C are as follows:
| Operating system | Requirement | Compatible Devices |
|---|---|---|
| iOS | • iOS 11.0 or later | • iPhone 6S and newer |
| • iPad 5 and newer | ||
| • iPad Air 2 and newer | ||
| • iPad Mini 4 and newer | ||
| • iPad Pro and newer | ||
| Android | • Android 5.0 (Lollipop) or later | • Samsung Galaxy S6 and newer |
| • Samsung Galaxy Note 5 and newer | ||
| • Samsung Galaxy Tab S3 and newer | ||
| Windows (UWP) | • Windows 10 (64-bit) or later | • Microsoft Surface Pro 3 and newer |
The SONON Ultrasound Imaging System is a portable, general-purpose, softwarecontrolled, hand-held diagnostic ultrasound system that consists of
6
- (i) a commercial off-the-shelf iOS or Android mobile device, or Windows PC
- the SONON Ultrasound Imaging System software that runs as an app on the (ii) mobile device,
- the battery-operated, hand-held SONON Ultrasound Imaging System (iii) transducer that communicates wirelessly with iOS or Android mobile devices, and
- the instructions for use manual, battery, charger, and power cords. (iv)
The SONON software can be downloaded to an iOS, Android mobile device or Windows PC and utilizes an icon touch-based user interface. The software enables ultrasound image capture and review, controls for time gain, dynamic range, display of mirror image, focal length, depth, brightness, contrast, linear/elliptical measurement, color flow, and image annotation, as well as storage and PACS transmission of images and videos.
The SONON Ultrasound Imaging System allows the user to image in real time and review cine or freeze-frame images on the screen in a B-Mode and Color Flow Doppler (CF Mode) Mode with 2-dimensional scan format. In addition, PW (pulsed wave) mode displays different wave velocities and directions in a spectrum. Moreover, in M mode (also known as "motion mode"), the changes over time on a line graph appears in a spectrum.
All images and data collected are stored in the mobile app. If the app is removed and reinstalled, all stored information is lost and cannot be recovered.
The SONON Ultrasound Imaging System utilizes pulsed-echo technology to determine the depth and location of tissue interfaces, and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. Ultrasound waves are emitted from the transducer, propagate through tissues, and return to the transducer as reflected echoes. The returned echoes are then converted into electrical impulses by transducer crystals and further processed in order to form the ultrasound image presented on the screen.
The device components are not supplied sterile and do not require sterilization prior to use.
Indications for Use 6.
The SONON Ultrasound Imaging System (Model: SONON 300C) is intended for diagnostic ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including obstetrics (OB), gynecology (GY) and general (abdominal) imaging. The system operating modes is B (Brightness), CF (color flow), PW (pulsed wave), M (motion). The intended to be used in a hospital or medical clinic is used by appropriately trained healthcare professionals, including radiologists, sonographers, technologists, and clinicians, in a medical facility.
7
7. Technological Comparison to Predicate Devices
| Table 1: Technological Comparison of Subject Device (i.e., SONON 300C and Predicate Device #1 (K151339)) | ||||
|---|---|---|---|---|
| The SONON Ultrasound Imaging System, | ||||
| Model: SONON 300C | The SONON Ultrasound Imaging System, | |||
| Model: SONON 300C | ||||
| K151339 | ||||
| (Predicate Device #1) | ||||
| Standard Feature | K# Unknown | |||
| (Subject Device) | Comparison | |||
| Indications for Use | The SONON Ultrasound Imaging System | |||
| (Model: SONON 300C) is intended for | ||||
| diagnostic ultrasound echo imaging, | ||||
| measurement, and analysis of the human body | ||||
| for general clinical applications including | ||||
| obstetrics (OB), gynecology (GY) and general | ||||
| (abdominal) imaging. The system operating | ||||
| modes is B (Brightness), CF (color flow), PW | ||||
| (pulsed wave), M (motion). The intended to be | ||||
| used in a hospital or medical clinic is used by | ||||
| appropriately trained healthcare professionals, | ||||
| including radiologists, sonographers, | ||||
| technologists, and clinicians, in a medical | ||||
| facility. | Intended for diagnostic ultrasound echo | |||
| imaging, measurement, and analysis of the | ||||
| human body for general clinical applications | ||||
| including obstetrics (OB), gynecology (GY) | ||||
| and general (abdominal) imaging. | Identical | |||
| Environment of Use | Hospital, clinic, and medical office settings | Hospital, clinic, and medical office settings | Identical | |
| Acoustic Output Levels | Below Track 3 FDA limits in accordance with | |||
| "Marketing Clearance of Diagnostic | ||||
| Ultrasound Systems and Transducers", June. | ||||
| 2019 | Below Track 3 FDA limits in accordance with | |||
| "Marketing Clearance of Diagnostic | ||||
| Ultrasound Systems and Transducers", June. | ||||
| 2019 | Identical | |||
| Imaging Capabilities | • pulsed-echo, pulsed-doppler | |||
| • Mode B (2D), Mode M (Motion), Mode CF | ||||
| (Color Flow), Mode PW (Pulsed Wave) | • pulsed-echo | |||
| • Mode B (2D) | Different | |||
| Patient Population | For use in all patients | For use in all patients | Identical | |
| Anatomic | ||||
| Structures/Clinical | ||||
| applications | general clinical applications including | |||
| obstetrics (OB), gynecology (GY) and | ||||
| general (abdominal) imaging | general clinical applications including | |||
| obstetrics (OB), gynecology (GY) and | ||||
| general (abdominal) imaging | Identical | |||
| Standard Feature | The SONON Ultrasound Imaging System, | |||
| Model: SONON 300C | ||||
| K# Unknown | ||||
| (Subject Device) | The SONON Ultrasound Imaging System, | |||
| Model: SONON 300C | ||||
| K151339 | ||||
| (Predicate Device #1) | Comparison | |||
| Users | appropriately trained healthcare | |||
| professionals | healthcare professionals | Identical | ||
| Probe Characteristics | Convex, 3.5 MHz | Convex, 3.5 MHz | Identical | |
| Probe Connection to | ||||
| Display | Wireless | Wireless | Identical | |
| Software | Type | Mobile application operating on Off-the-shelf | ||
| Operating Systems | Mobile application operating on Off-the-shelf | |||
| Operating Systems | Identical | |||
| Compatible | ||||
| OS | iOS / Android / Windows | iOS / Android | Different | |
| Patient-Contacting | ||||
| Materials | All patient-contact materials are | |||
| biocompatible and can be disinfected | All patient-contact materials are | |||
| biocompatible and can be disinfected | Identical | |||
| Reusable? | Yes | Yes | Identical | |
| Duration of Use | Limited ( |